← SynDRA
PICEATANNOL
SynDRA canonical compound SYN0003023 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ATP5A1 | ATP5B | ATP5C1 | IRF3 | PTGS2 | SIRT1 | SYK | TYR |
| Mechanism of action | SYK inhibitor |
All known targets
- IRF3
- ATP5F1A
- ATP5F1B
- ATP5F1C
- PTGS2
- SIRT1
- SYK
- TYR
Mechanisms of action (all sources)
- SYK INHIBITOR
- IRF3 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADAMTS4
- POLK
- POLH
- POLB
- PMP22
- PLK4
- PLK1
- PIM3
- PIM2
- PIM1
- PDPK1
- PBK
- PAK6
- PAK5
- PAK4
- OXSR1
- NPC1
- NFE2L2
- NEK6
- NEK2
- MYLK
- MTOR
- MPHOSPH8
- MMP9
- MMP8
- MMP2
- MMP12
- MBNL1
- MAPT
- POLI
- PRKAA2
- MAPK3
- PRKACA
- VRK2
- VRK1
- TTR
- TRPA1
- TP53
- TNIK
- THRB
Cross-references
Synonyms
- 3-Hydroxyresveratol
- piceatanol
- astringinin
- 3,5,3',4'-Tetrahydroxystilbene
- (E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol
- 3,3',4'5-Tetrahydroxystilbene
- 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol
- 3,3',4,5'-Tetrahydroxystilbene
- UNII-6KS3LS0D4F
- NSC-365798
- NSC 622471
- 6KS3LS0D4F
- CHEMBL69863
- 3,3',4,5'-Stilbenetetrol
- 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol
- CHEBI:28814
- C14H12O4
- NSC365798
- NSC622471
- 1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-
- trans-Piceatannol
- (E)-Piceatannol
- Astringenin
- 3,4,3',5'-tetrahydroxy-trans-stilbene
- NSC 365798
- trans-3,3',4,5'-Tetrahydroxystilbene
- 3,3',4,5'-Tetrahydroxy-trans-stilbene
- J61.264B
- C05901
- 3,3',4,5'-STILBENETETROL, (E)-
- 4-((E)-2-(3,5-DIHYDROXYPHENYL)ETHENYL)BENZENE-1,2-DIOL
- 4-((E)-2-(3,5-DIHYDROXYPHENYL)VINYL)-1,2-BENZENEDIOL
- 4-((E)-2-(3,5-dihydroxyphenyl)vinyl)benzene-1,2-diol
- 4-((1E)-2-(3,5-dihydroxyphenyl)ethenyl)benzene-1,2-diol
- 4-[(1E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol
- RefChem:44580
- cis-Piceatannol
Look up PICEATANNOL in the interactive SynDRA portal →